Li Shuo, Xiao Yiding, Wang He, Liu Zhifei
Department of Plastic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China.
Department of Neurological Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China.
Clin Cosmet Investig Dermatol. 2022 May 30;15:981-985. doi: 10.2147/CCID.S366432. eCollection 2022.
Nevus lipomatosus cutaneous superficialis (NLCS) is a rare hamartoma of adipose tissue characterized by the ectopic build-up of adipose tissue among collagen bundles and proliferation of ectopic adipocytes in the dermis, which leads to an absence of connection to the subcutaneous tissue. Giant NLCS (over 15 × 15 cm) is even rarer. So far, the largest NLCS mass in the literature was a giant lesion measuring 50 × 50 cm on the sacral area reported in 2014. Herein, we report a case of an even larger NLCS lesion with a size of 106 × 30 cm on the back and sacral regions. These lesions had been left untreated and had grown from small yellowish papules and nodules to giant multilocular pedunculated masses with cerebriform surfaces over 24 years. To the best of our knowledge, the NLCS lesion presented here is the largest reported. The report aimed to increase clinicians' awareness of this rare and easily misdiagnosed disease. Furthermore, physicians should be mindful that early recognition and appropriate treatment are essential for NLCS patients, and lesions of NLCS can coalesce into unimaginable huge masses if left untreated resulting in more significant therapeutic challenges.
浅表性脂肪瘤样痣(NLCS)是一种罕见的脂肪组织错构瘤,其特征是真皮内胶原束间异位脂肪组织堆积以及异位脂肪细胞增殖,导致与皮下组织无连接。巨大NLCS(超过15×15厘米)更为罕见。迄今为止,文献中报道的最大NLCS肿块是2014年报告的骶尾部一个大小为50×50厘米的巨大病变。在此,我们报告一例更大的NLCS病变,位于背部和骶尾部,大小为106×30厘米。这些病变一直未得到治疗,在24年里从小的淡黄色丘疹和结节发展为巨大的多房带蒂肿块,表面呈脑回状。据我们所知,此处呈现的NLCS病变是已报道的最大的。该报告旨在提高临床医生对这种罕见且易误诊疾病的认识。此外,医生应注意,早期识别和适当治疗对NLCS患者至关重要,如果不治疗,NLCS病变可融合成难以想象的巨大肿块,从而带来更严峻的治疗挑战。